Related Experiment Video
Updated: May 12, 2026
07:25
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Zoledronic acid in genitourinary cancer
M A Climent1, U Anido, M J Méndez-Vidal
1Servicio de Oncología Médica, Instituto Valenciano de Oncología (IVO), C/Beltrán Báguena, 8, 46009, Valencia, Spain, macliment@fivo.org.
Summary
Bone metastases are common in advanced genitourinary (GU) cancers. Zoledronic acid, a bisphosphonate, helps prevent skeletal complications and bone pain in patients with bone metastases.
Area of Science:
- Oncology
- Pharmacology
- Urology
Background:
- Bone metastases are a frequent complication in advanced prostate cancer.
- They also occur in advanced renal cell carcinoma and bladder cancer, affecting up to 35% of patients.
- In bladder cancer patients with distant metastases, bone involvement exceeds two-thirds.
Purpose of the Study:
- To evaluate the efficacy of zoledronic acid in managing bone metastases from genitourinary (GU) cancers.
- To assess zoledronic acid's role in preventing skeletal-related events and reducing bone pain.
- To determine zoledronic acid's potential in preventing osteopenia associated with cancer therapies.
Main Methods:
- Review of existing literature on bone metastases in GU malignancies.
- Analysis of clinical data regarding the use of zoledronic acid in affected patients.
- Evaluation of zoledronic acid's impact on skeletal complications and bone pain.
Main Results:
- Without bone-targeted therapies, 50% of GU cancer patients with bone metastases experience skeletal events.
- Zoledronic acid delays or prevents skeletal complications in patients with bone metastases.
- Zoledronic acid reduces bone pain and helps prevent osteopenia.
Conclusions:
- Zoledronic acid is effective in managing bone metastases from GU cancers.
- It significantly reduces the incidence of skeletal-related events and alleviates bone pain.
- It also plays a role in preventing treatment-induced osteopenia.
Related Concept Videos
01:30Urinary Tract Calculi III: Medical Management
The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
01:27Urinary Tract Calculi IV: Nutrition Therapy and Prevention
Management of renal calculi focuses on effective strategies like tailored nutrition and hydration therapy. Adjusting diet and fluid intake reduces stone formation and recurrence, making these interventions simple yet powerful in kidney stone prevention and management.Understanding Kidney StonesKidney stones form when calcium, oxalate, uric acid, and cystine concentrate and crystallize in urine. Factors contributing to their formation include genetic predisposition, certain medical conditions,...
01:28Urinary Tract Calculi V: Nursing Management
AssessmentSubjective Data: Obtain a detailed health history, including any recent or chronic urinary tract infections, periods of immobilization, previous episodes of renal calculi, and medical conditions such as gout, benign prostatic hyperplasia, or hyperparathyroidism. Review the medication history for drugs that may influence stone formation, including allopurinol, analgesics, loop diuretics, or thiazide diuretics. Document the use of long-term indwelling catheters and any past surgical...
01:13Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
01:31Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
In the complex environment of the gastric lumen, excessive acid secretion can lead to the formation or worsening of ulcers within the delicate mucosal layer. Antacids, such as sodium bicarbonate and calcium carbonate, provide relief by neutralizing this acid, transforming it into harmless salt and water. This neutralization process raises the gastric pH from a highly acidic level of 1 to a more basic 3-4, reducing the acidity within the stomach.
However, this neutralization reaction between...
However, this neutralization reaction between...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...